Both in Pharmaceuticals
Zevra Therapeutics vs Obsidian Therapeutics
Over the past year ZVRA returned −7.0% and OBX returned −38.3%; their daily moves had a correlation of 0.12.
ZVRA −7.0% OBX −38.3%Growth of $1, one year, split-adjusted
| Metric | ZVRA | OBX |
|---|---|---|
| Price | $11.17 | $10.99 |
| Market cap | $663.3M | $678.9M |
| Today | +8.87% | −16.93% |
| 1 month | +4.1% | −16.9% |
| 6 months | −0.7% | — |
| Year to date | +24.7% | — |
| 1 year | +9.4% | — |
| Revenue growth (YoY) | +44.9% | — |
| Gross margin | 95.2% | — |
| Net margin | 48.8% | — |
| P/E (TTM) | 8.6× | — |
| Price / sales | 4.5× | — |
| Net cash | $188.3M | — |
| Dividend yield | — | — |
| Volatility (60d) | 47.6% | — |
| Short % of float | 10.8% | 2.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).